<Record>
<Term>Congenital Generalized Lipodystrophy</Term>
<SemanticType>Disease or Syndrome</SemanticType>
<ParentTerm>Lipodystrophy</ParentTerm>
<ClassificationPath>Nutritional and Metabolic Diseases/Metabolic Diseases/Skin Diseases, Metabolic/Lipodystrophy/Lipodystrophy, Congenital Generalized</ClassificationPath>
<ClassificationPath>Nutritional and Metabolic Diseases/Metabolic Diseases/Lipid Metabolism Disorders/Lipodystrophy/Lipodystrophy, Congenital Generalized</ClassificationPath>
<ClassificationPath>Skin and Connective Tissue Diseases/Skin Diseases/Skin Diseases, Metabolic/Lipodystrophy/Lipodystrophy, Congenital Generalized</ClassificationPath>
<BroaderTerm>Lipid Metabolism Disorders</BroaderTerm>
<BroaderTerm>Metabolic Diseases</BroaderTerm>
<BroaderTerm>Skin Diseases, Metabolic</BroaderTerm>
<BroaderTerm>Skin Diseases</BroaderTerm>
<BroaderTerm>Nutritional and Metabolic Diseases</BroaderTerm>
<BroaderTerm>Skin and Connective Tissue Diseases</BroaderTerm>
<BroaderTerm>Lipodystrophy, Congenital Generalized</BroaderTerm>
<BroaderTerm>Lipodystrophy</BroaderTerm>
<Synonym>Berardinelli-Seip Congenital Lipodystrophy</Synonym>
<Synonym>Berardinelli Seip Congenital Lipodystrophy</Synonym>
<Synonym>Congenital Generalized Lipodystrophy</Synonym>
<Synonym>Congenital Generalized Lipodystrophy Type 1</Synonym>
<Synonym>Congenital Generalized Lipodystrophies</Synonym>
<Synonym>Congenital Generalized Lipodystrophy Type 2</Synonym>
<Description>Congenital disorders, usually autosomal recessive, characterized by severe generalized lack of ADIPOSE TISSUE, extreme INSULIN RESISTANCE, and HYPERTRIGLYCERIDEMIA.It is caused by mutation of gene encoding seipin (BSCL2).It is caused by mutations of gene encoding 1-acylglycerol-3-phosphate O-acyltransferase-2 (AGPAT2).</Description>
<Source>MeSH</Source>
</Record>
